Lonza invests in ‘game-changer’ automated cell therapy manufacture 31-Oct-2018 By Ben Hargreaves After a three-year partnership, Lonza pulled the trigger on acquiring a controlling stake of Octane Biotech and their jointly developed Cocoon system.